Evoke Wealth’s bluebird bio BLUE Stock Holding History

Evoke Wealth’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	-$1.47K	–	1272
2019 Q3	$1.47K	Buy	+1	New	+$1.53K	﹤0.01%	1267

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Evoke Wealth's BLUE Position: Q4 2019 in Review

Evoke Wealth sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 1 share — an estimated $1.47K sold.

Evoke Wealth first reported a position in BLUE in Q3 2019 and held it in 1 quarter. The position peaked at $1.47K in Q3 2019. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

Evoke Wealth reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
Evoke Wealth sold 1 bluebird bio share in Q4 2019, an estimated $1.47K.
Evoke Wealth first reported a position in bluebird bio in Q3 2019 and held it in 1 quarter.
Evoke Wealth's bluebird bio position peaked at $1.47K in Q3 2019.
274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on Evoke Wealth's 13F filing for Q4 2019, filed 7 Feb 2020.